Followers | 1006 |
Posts | 30920 |
Boards Moderated | 0 |
Alias Born | 01/19/2010 |
Thursday, April 11, 2024 11:53:15 AM
She's got that look!
DISCLAIMER: All my posts are MY OPINION and are not to be used as investment or trading advice. My posts are for entertainment purposes only. If you wish to Invest or trade, seek help from a Licensed broker.
Recent CADL News
- Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer • GlobeNewswire Inc. • 04/11/2024 01:00:00 PM
- Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors • GlobeNewswire Inc. • 04/09/2024 12:00:00 PM
- Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma • GlobeNewswire Inc. • 03/28/2024 08:05:00 PM
- Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 03/28/2024 12:05:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:00:10 PM
- Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/13/2024 02:00:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 12:45:10 PM
- CAN-3110 Receives FDA Fast Track Designation for Treatment of Recurrent High-Grade Glioma • GlobeNewswire Inc. • 02/13/2024 12:30:00 PM
- Candel Therapeutics Sets Path to Success: Recent Achievements Pave the Way for a Promising 2024 Propelled by Key Value Drivers and Catalysts • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 01:30:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 09:30:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:30:08 PM
- Candel Therapeutics Shares Soar After FDA Fast Track of CAN-2409 • Dow Jones News • 12/12/2023 01:58:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 01:30:56 PM
- Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer • GlobeNewswire Inc. • 12/12/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:00:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:30:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:30:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 09:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 02:00:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM